Validation of T2- and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated radiotherapy (IMRT)
Highlights•5 mm mapping prostate biopsies correlated with imaged intra-prostatic tumour. •Diffusion-restricted tumour of ≥0.5 cm 3 can be dose-escalated with confidence. •Tumours of
Gespeichert in:
| Veröffentlicht in: | Radiotherapy and oncology 2019-12, Vol.141, p.181-187 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 187 |
|---|---|
| container_issue | |
| container_start_page | 181 |
| container_title | Radiotherapy and oncology |
| container_volume | 141 |
| creator | Alexander, E.J Murray, J.R Morgan, V.A Giles, S.L Riches, S.F Hazell, S Thomas, K Sohaib, S.A Thompson, A Gao, A Dearnaley, D.P DeSouza, N.M |
| description | Highlights•5 mm mapping prostate biopsies correlated with imaged intra-prostatic tumour. •Diffusion-restricted tumour of ≥0.5 cm 3 can be dose-escalated with confidence. •Tumours of |
| doi_str_mv | 10.1016/j.radonc.2019.07.030 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6908966</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0167814019330233</els_id><sourcerecordid>1_s2_0_S0167814019330233</sourcerecordid><originalsourceid>FETCH-LOGICAL-c518t-ad4edbd98f1290711469c7b71be911a45890529c0f0104bd247942d955b1329d3</originalsourceid><addsrcrecordid>eNqFUk2P0zAQjRCILQv_ACEf4ZAyjtMmviCh1S6stAgJClfLsSetS2pHtruoP41_txMFlo8LJ1szb97MmzdF8ZzDkgNfv94vo7bBm2UFXC6hWYKAB8WCt40soW2bh8WCYE3Z8hrOiicp7QGgAtE8Ls4Er6WQUC-KH1_14KzOLngWerapSqa9Zdb1_TFRsPyObrvLaNlBbz1mZ1jEFLz2BpmjmPNb1odI6XGc_s7nqMsxhpT1hM7HQzhGNkZHoBwIa_TAukB5ZkPCEhMF5gGo48yAPrl8Kg_BHilFzUmqC3mHUY8n9vL6w6fNq6fFo14PCZ_9fM-LL1eXm4v35c3Hd9cXb29Ks-JtLrWt0XZWtj2vJDSc12tpmq7hHUrOdb1qJawqaaAHDnVnq7qRdWXlatVxUUkrzos3M-947A5oDU4CB0WCDjqeVNBO_Z3xbqe24VatJbRyvSaCeiYwtJQUsb-v5aAmK9VezVaqyUoFjSIrqezFn33vi35593swJPW3DqNKxiH5Yl1Ek5UN7n8d_iUwg_OO7PiGJ0x78s3TZhVXqVKgPk_nNF0Tl0JAJYS4A4QEzCU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Validation of T2- and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated radiotherapy (IMRT)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Alexander, E.J ; Murray, J.R ; Morgan, V.A ; Giles, S.L ; Riches, S.F ; Hazell, S ; Thomas, K ; Sohaib, S.A ; Thompson, A ; Gao, A ; Dearnaley, D.P ; DeSouza, N.M</creator><creatorcontrib>Alexander, E.J ; Murray, J.R ; Morgan, V.A ; Giles, S.L ; Riches, S.F ; Hazell, S ; Thomas, K ; Sohaib, S.A ; Thompson, A ; Gao, A ; Dearnaley, D.P ; DeSouza, N.M</creatorcontrib><description>Highlights•5 mm mapping prostate biopsies correlated with imaged intra-prostatic tumour. •Diffusion-restricted tumour of ≥0.5 cm 3 can be dose-escalated with confidence. •Tumours of <0.5 cm 3 should not be dose-escalated. •Diffusion-weighted MR has good diagnostic accuracy for dominant tumour lesions.</description><identifier>ISSN: 0167-8140</identifier><identifier>EISSN: 1879-0887</identifier><identifier>DOI: 10.1016/j.radonc.2019.07.030</identifier><identifier>PMID: 31493904</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Aged ; Diagnostic accuracy ; Diffusion Magnetic Resonance Imaging - methods ; Hematology, Oncology, and Palliative Medicine ; Humans ; Image-Guided Biopsy - methods ; Image-guided radiotherapy ; Magnetic resonance imaging ; Male ; Mapping biopsies ; Middle Aged ; Prospective Studies ; Prostate cancer ; Prostate radiotherapy ; Prostatic Neoplasms - diagnostic imaging ; Prostatic Neoplasms - pathology ; Prostatic Neoplasms - radiotherapy ; Radiotherapy Dosage ; Radiotherapy, Intensity-Modulated - methods</subject><ispartof>Radiotherapy and oncology, 2019-12, Vol.141, p.181-187</ispartof><rights>The Authors</rights><rights>2019 The Authors</rights><rights>Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.</rights><rights>2019 The Authors 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c518t-ad4edbd98f1290711469c7b71be911a45890529c0f0104bd247942d955b1329d3</citedby><cites>FETCH-LOGICAL-c518t-ad4edbd98f1290711469c7b71be911a45890529c0f0104bd247942d955b1329d3</cites><orcidid>0000-0003-2357-2063 ; 0000-0003-4232-476X ; 0000-0002-3954-2806</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0167814019330233$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31493904$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alexander, E.J</creatorcontrib><creatorcontrib>Murray, J.R</creatorcontrib><creatorcontrib>Morgan, V.A</creatorcontrib><creatorcontrib>Giles, S.L</creatorcontrib><creatorcontrib>Riches, S.F</creatorcontrib><creatorcontrib>Hazell, S</creatorcontrib><creatorcontrib>Thomas, K</creatorcontrib><creatorcontrib>Sohaib, S.A</creatorcontrib><creatorcontrib>Thompson, A</creatorcontrib><creatorcontrib>Gao, A</creatorcontrib><creatorcontrib>Dearnaley, D.P</creatorcontrib><creatorcontrib>DeSouza, N.M</creatorcontrib><title>Validation of T2- and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated radiotherapy (IMRT)</title><title>Radiotherapy and oncology</title><addtitle>Radiother Oncol</addtitle><description>Highlights•5 mm mapping prostate biopsies correlated with imaged intra-prostatic tumour. •Diffusion-restricted tumour of ≥0.5 cm 3 can be dose-escalated with confidence. •Tumours of <0.5 cm 3 should not be dose-escalated. •Diffusion-weighted MR has good diagnostic accuracy for dominant tumour lesions.</description><subject>Aged</subject><subject>Diagnostic accuracy</subject><subject>Diffusion Magnetic Resonance Imaging - methods</subject><subject>Hematology, Oncology, and Palliative Medicine</subject><subject>Humans</subject><subject>Image-Guided Biopsy - methods</subject><subject>Image-guided radiotherapy</subject><subject>Magnetic resonance imaging</subject><subject>Male</subject><subject>Mapping biopsies</subject><subject>Middle Aged</subject><subject>Prospective Studies</subject><subject>Prostate cancer</subject><subject>Prostate radiotherapy</subject><subject>Prostatic Neoplasms - diagnostic imaging</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Prostatic Neoplasms - radiotherapy</subject><subject>Radiotherapy Dosage</subject><subject>Radiotherapy, Intensity-Modulated - methods</subject><issn>0167-8140</issn><issn>1879-0887</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUk2P0zAQjRCILQv_ACEf4ZAyjtMmviCh1S6stAgJClfLsSetS2pHtruoP41_txMFlo8LJ1szb97MmzdF8ZzDkgNfv94vo7bBm2UFXC6hWYKAB8WCt40soW2bh8WCYE3Z8hrOiicp7QGgAtE8Ls4Er6WQUC-KH1_14KzOLngWerapSqa9Zdb1_TFRsPyObrvLaNlBbz1mZ1jEFLz2BpmjmPNb1odI6XGc_s7nqMsxhpT1hM7HQzhGNkZHoBwIa_TAukB5ZkPCEhMF5gGo48yAPrl8Kg_BHilFzUmqC3mHUY8n9vL6w6fNq6fFo14PCZ_9fM-LL1eXm4v35c3Hd9cXb29Ks-JtLrWt0XZWtj2vJDSc12tpmq7hHUrOdb1qJawqaaAHDnVnq7qRdWXlatVxUUkrzos3M-947A5oDU4CB0WCDjqeVNBO_Z3xbqe24VatJbRyvSaCeiYwtJQUsb-v5aAmK9VezVaqyUoFjSIrqezFn33vi35593swJPW3DqNKxiH5Yl1Ek5UN7n8d_iUwg_OO7PiGJ0x78s3TZhVXqVKgPk_nNF0Tl0JAJYS4A4QEzCU</recordid><startdate>20191201</startdate><enddate>20191201</enddate><creator>Alexander, E.J</creator><creator>Murray, J.R</creator><creator>Morgan, V.A</creator><creator>Giles, S.L</creator><creator>Riches, S.F</creator><creator>Hazell, S</creator><creator>Thomas, K</creator><creator>Sohaib, S.A</creator><creator>Thompson, A</creator><creator>Gao, A</creator><creator>Dearnaley, D.P</creator><creator>DeSouza, N.M</creator><general>Elsevier B.V</general><general>Elsevier Scientific Publishers</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2357-2063</orcidid><orcidid>https://orcid.org/0000-0003-4232-476X</orcidid><orcidid>https://orcid.org/0000-0002-3954-2806</orcidid></search><sort><creationdate>20191201</creationdate><title>Validation of T2- and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated radiotherapy (IMRT)</title><author>Alexander, E.J ; Murray, J.R ; Morgan, V.A ; Giles, S.L ; Riches, S.F ; Hazell, S ; Thomas, K ; Sohaib, S.A ; Thompson, A ; Gao, A ; Dearnaley, D.P ; DeSouza, N.M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c518t-ad4edbd98f1290711469c7b71be911a45890529c0f0104bd247942d955b1329d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aged</topic><topic>Diagnostic accuracy</topic><topic>Diffusion Magnetic Resonance Imaging - methods</topic><topic>Hematology, Oncology, and Palliative Medicine</topic><topic>Humans</topic><topic>Image-Guided Biopsy - methods</topic><topic>Image-guided radiotherapy</topic><topic>Magnetic resonance imaging</topic><topic>Male</topic><topic>Mapping biopsies</topic><topic>Middle Aged</topic><topic>Prospective Studies</topic><topic>Prostate cancer</topic><topic>Prostate radiotherapy</topic><topic>Prostatic Neoplasms - diagnostic imaging</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Prostatic Neoplasms - radiotherapy</topic><topic>Radiotherapy Dosage</topic><topic>Radiotherapy, Intensity-Modulated - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alexander, E.J</creatorcontrib><creatorcontrib>Murray, J.R</creatorcontrib><creatorcontrib>Morgan, V.A</creatorcontrib><creatorcontrib>Giles, S.L</creatorcontrib><creatorcontrib>Riches, S.F</creatorcontrib><creatorcontrib>Hazell, S</creatorcontrib><creatorcontrib>Thomas, K</creatorcontrib><creatorcontrib>Sohaib, S.A</creatorcontrib><creatorcontrib>Thompson, A</creatorcontrib><creatorcontrib>Gao, A</creatorcontrib><creatorcontrib>Dearnaley, D.P</creatorcontrib><creatorcontrib>DeSouza, N.M</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Radiotherapy and oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alexander, E.J</au><au>Murray, J.R</au><au>Morgan, V.A</au><au>Giles, S.L</au><au>Riches, S.F</au><au>Hazell, S</au><au>Thomas, K</au><au>Sohaib, S.A</au><au>Thompson, A</au><au>Gao, A</au><au>Dearnaley, D.P</au><au>DeSouza, N.M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Validation of T2- and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated radiotherapy (IMRT)</atitle><jtitle>Radiotherapy and oncology</jtitle><addtitle>Radiother Oncol</addtitle><date>2019-12-01</date><risdate>2019</risdate><volume>141</volume><spage>181</spage><epage>187</epage><pages>181-187</pages><issn>0167-8140</issn><eissn>1879-0887</eissn><abstract>Highlights•5 mm mapping prostate biopsies correlated with imaged intra-prostatic tumour. •Diffusion-restricted tumour of ≥0.5 cm 3 can be dose-escalated with confidence. •Tumours of <0.5 cm 3 should not be dose-escalated. •Diffusion-weighted MR has good diagnostic accuracy for dominant tumour lesions.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>31493904</pmid><doi>10.1016/j.radonc.2019.07.030</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-2357-2063</orcidid><orcidid>https://orcid.org/0000-0003-4232-476X</orcidid><orcidid>https://orcid.org/0000-0002-3954-2806</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0167-8140 |
| ispartof | Radiotherapy and oncology, 2019-12, Vol.141, p.181-187 |
| issn | 0167-8140 1879-0887 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6908966 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Aged Diagnostic accuracy Diffusion Magnetic Resonance Imaging - methods Hematology, Oncology, and Palliative Medicine Humans Image-Guided Biopsy - methods Image-guided radiotherapy Magnetic resonance imaging Male Mapping biopsies Middle Aged Prospective Studies Prostate cancer Prostate radiotherapy Prostatic Neoplasms - diagnostic imaging Prostatic Neoplasms - pathology Prostatic Neoplasms - radiotherapy Radiotherapy Dosage Radiotherapy, Intensity-Modulated - methods |
| title | Validation of T2- and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated radiotherapy (IMRT) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T07%3A24%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Validation%20of%20T2-%20and%20diffusion-weighted%20magnetic%20resonance%20imaging%20for%20mapping%20intra-prostatic%20tumour%20prior%20to%20focal%20boost%20dose-escalation%20using%20intensity-modulated%20radiotherapy%20(IMRT)&rft.jtitle=Radiotherapy%20and%20oncology&rft.au=Alexander,%20E.J&rft.date=2019-12-01&rft.volume=141&rft.spage=181&rft.epage=187&rft.pages=181-187&rft.issn=0167-8140&rft.eissn=1879-0887&rft_id=info:doi/10.1016/j.radonc.2019.07.030&rft_dat=%3Celsevier_pubme%3E1_s2_0_S0167814019330233%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/31493904&rft_els_id=1_s2_0_S0167814019330233&rfr_iscdi=true |